AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Met-G2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Bi-Cure Remedies

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Met-G2 Tablet SR

Glimepiride-Metformin extended-release tablets are categorized as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision can lead to elevated glucose, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Uses of Met-G2 Tablet SR

Managing type 2 diabetes

Major Benefits of Met-G2 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Met-G2 SR tablet should be administered with a meal.

Common Side effects of Met-G2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Met-G2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Met-G2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Met-G2 Tablet SR works:

Metformin and Glimepiride, combined as Met-G2 SR tablets, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Met-G2 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Met-G2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Met-G2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Met-G2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Met-G2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Met-G2 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, Met-G2 Tablet SR is typically initiated at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Met-G2 Tablet SR :

Should you forget a Met-G2 Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Met-G2 Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Met-G2 Tablet SR

Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medicine. Ensure the medication remains inaccessible to children, animals, and other individuals.
Met-G2 Tablet SR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms may involve muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow pulse. If any of these occur, discontinue Met-G2 Tablet SR and seek immediate medical attention.
Met-G2 SR tablets contain glimepiride and metformin, a dual-action medication for managing type 2 diabetes mellitus in adults. This therapy enhances blood sugar control when coupled with a healthy diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin acts by decreasing hepatic glucose production and boosting insulin responsiveness. This combination is unsuitable for treating type 1 diabetes.
Taking Met-G2 Tablet SR may result in frequent side effects such as low blood sugar, taste changes, queasiness, abdominal discomfort, loose stools, and head pain. Rare but potentially severe adverse reactions include lactic acidosis. Prolonged use might additionally cause a deficiency in vitamin B12.
Prolonged Met-G2 Tablet SR administration can induce Vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may lead to anemia, neurological complications manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate these risks, supplemental Vitamin B12 is recommended by some experts at least annually.
Indeed, Met-G2 Tablet SR can induce hypoglycemia—low blood glucose. Manifestations of this condition encompass nausea, cephalalgia, irritability, polyphagia, diaphoresis, vertigo, tachycardia, and feelings of apprehension or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Consuming alcohol concurrently with Met-G2 Tablet SR is unsafe due to the risk of significantly reduced blood glucose, potentially causing hypoglycemia. Furthermore, this combination elevates the likelihood of lactic acidosis.
Met-G2 Tablet SR
60
MRP 73
17% off